Experimental immunisation of lambs against pneumonic pasteurellosis

Area of Science:

• Veterinary immunology
• Bacterial disease research
• Sheep health

Background:

• Pneumonic pasteurellosis, caused by Pasteurella haemolytica, is a significant respiratory disease in lambs.
• Effective immunization strategies are crucial for controlling outbreaks and improving flock health.
• Previous methods may have limitations in broad serotype protection.

Purpose of the Study:

• To evaluate the efficacy of sodium salicylate extract (SSE) of Pasteurella haemolytica as a vaccine component.
• To assess the protective effects of SSE, alone or combined with heat-killed organisms (HKO), against pneumonic pasteurellosis.
• To determine the effectiveness of immunization against specific serotypes of P. haemolytica.

Main Methods:

• Specific pathogen-free lambs were used to minimize confounding factors.
• Vaccination involved intramuscular administration of P. haemolytica SSE, with or without HKO.
• Lambs were subsequently challenged with homologous serotypes of P. haemolytica to assess protection against pneumonia.

Main Results:

• SSE derived from P. haemolytica type A1 demonstrated significant protection against homologous challenge.
• SSE from P. haemolytica type A2 provided partial protection.
• Combining SSE with HKO for type A2 vaccination enhanced the protective effect compared to SSE alone.

Conclusions:

• Sodium salicylate extract (SSE) of P. haemolytica is a viable component for vaccines against pneumonic pasteurellosis.
• Vaccine formulations combining SSE and HKO may offer improved and broader serotype protection.
• Further research into optimizing vaccine strategies for different P. haemolytica serotypes is warranted.